The potential of TB treatment 8 weeks

Published Date: 08 Mar 2023

While some say this strategy's failure rate is "too high," it's one step closer to the "white grail" of a shorter 24-week formula.

Read Full News

Latest News

US Widens Lettuce-related Cyclosporiasis Probe to 20 States

U.S. health authorities have widened their probe into a cyclosporiasis outbreak tied to iceberg lettuce ⁠from central Mexico after detecting cases in three additional...

US FDA Approves Updated COVID Vaccines for 2026-27 Season

The U.S. Food and Drug Administration approved Moderna, Novavax-Sanofi ⁠and Pfizer-BioNTech's updated COVID vaccines, the companies said on Thursday, ⁠after an advisory...

HIV Resistance Assay Offers Quick, Low-Cost Results for RTs

The assay’s significant limitation is its inability to assess drug resistance for integrase inhibitors, including dolutegravir, a first-line drug with growing resistance.

Congo Starts Ebola Vaccinations for Health Workers

Democratic Republic of Congo on Thursday began vaccinating frontline health workers with a vaccine ⁠approved for a different Ebola species, as authorities seek to contain...

Dolutegravir ART Receives FDA Approval for Newborns With HIV

As the first second-generation INSTI approved for newborns with HIV, this approval allows for a simpler, more robust antiretroviral therapy regimen than existing standard of care.

Groups Work to Save Lives as Ebola Spreads in Central Africa

Even though the virus has faded from US headlines, key organizations are still at work providing medical care and training to counter the spread of the disease.

Todays Updates

Thymus Radiation Exposure Tied to Worse Lung Cancer Outcomes

The thymus is not routinely considered during thoracic radiotherapy planning, but new findings suggest that may need to change.

FDA Approves Rusfertide for Polycythemia Vera

Adding rusfertide to standard-of-care treatment cut phlebotomy rates by more than half in the phase 3 VERIFY trial.

Todays Updates

Thymus Radiation Exposure Tied to Worse Lung Cancer Outcomes

The thymus is not routinely considered during thoracic radiotherapy planning, but new findings suggest that may need to change.

FDA Approves Rusfertide for Polycythemia Vera

Adding rusfertide to standard-of-care treatment cut phlebotomy rates by more than half in the phase 3 VERIFY trial.

Latest News

U.S. health authorities have widened their probe into a cyclosporiasis outbreak tied to iceberg lettuce ⁠from central Mexico after detecting cases in three additional...

The U.S. Food and Drug Administration approved Moderna, Novavax-Sanofi ⁠and Pfizer-BioNTech's updated COVID vaccines, the companies said on Thursday, ⁠after an advisory...

The assay’s significant limitation is its inability to assess drug resistance for integrase inhibitors, including dolutegravir, a first-line drug with growing resistance.

Democratic Republic of Congo on Thursday began vaccinating frontline health workers with a vaccine ⁠approved for a different Ebola species, as authorities seek to contain...

As the first second-generation INSTI approved for newborns with HIV, this approval allows for a simpler, more robust antiretroviral therapy regimen than existing standard of care.

Even though the virus has faded from US headlines, key organizations are still at work providing medical care and training to counter the spread of the disease.

News All Time

Dengue Cases Surge in Malaysia's Klang Valley, Says Health Ministry

Dengue fever cases have surged in the Malaysian capital Kuala Lumpur and the surrounding Klang Valley area, the ⁠country's health ministry said on Friday, warning of a high...

Michigan Reports About 3% Weekly Rise in Cyclosporiasis Cases as Outbreak Begins to Slow

Michigan's health department on Thursday reported 14,277 cases linked to a cyclosporiasis outbreak, up 368 or about 3% from a week earlier, with the slower ⁠pace of increase...

Congo Set to Receive 70,000 Ervebo Vaccines to Contain Ebola Outbreak, WHO Says

The Democratic Republic of Congo has been allocated 70,000 doses of Merck's Ervebo vaccine for Ebola, the World Health ⁠Organization said on Thursday, as the country...

Lenacapavir PrEP: No New HIV infections & High Satisfaction

Participants in the PURPOSE 1 trial particularly appreciated the convenience of not needing a daily pill and the confidence of feeling protected from HIV long-term.

Ebola Cases in Congo Exceed 5,000, Government Data Shows

The number of confirmed Ebola cases in the Democratic Republic ⁠of Congo now exceeds 5,000, government data showed late on Tuesday, as ⁠health officials warn that response...

Kids With Complex Conditions Face Higher Antibiotic Exposure

Children with complex chronic conditions have a higher likelihood of receiving antibiotic prescriptions than their healthy peers.

Doravirine Add-On Boosts Virologic Control in HIV Infection

Adding doravirine to an existing antiretroviral regimen helps people living with HIV regain virologic control, especially when background drugs remain active.

WHO Says Congo Ebola Outbreak Can Still Be Brought Under Control Within Three Months

A World Health Organization official said on Tuesday it was still possible to bring under control an ⁠Ebola outbreak that is outpacing containment efforts and has become the...

Do TZP-Resistant Bloodstream Infections Raise Death Risk?

Piperacillin-tazobactam resistance does not increase mortality risk in patients with bloodstream infections after accounting for baseline risk factors, a recent study shows.

Data Trends: Pneumococcal Disease Prevention

Pneumococcal disease prevention is evolving fast with updated vaccine recommendations for adults 50+ and exciting next-generation vaccines on the horizon.

Ebola Outbreak in Democratic Republic Of Congo Becomes Deadliest in Country's History

The Ebola outbreak in Democratic Republic of Congo has killed 2,325 people, government data showed on Sunday, surpassing the toll from the 2018-2020 outbreak to become the...

Netherlands Reports First West Nile Virus Infection in 6 Years

A West Nile virus infection has ⁠been detected in the Netherlands for the first ⁠time since 2020, Dutch public health institution ⁠RIVM said on ‌Monday.

Doxycycline Cuts Recurrent Rectal Chlamydia Risk

A shift in prescribing practices at a Seattle sexual health clinic corresponded with a notable decline in recurrent rectal chlamydia cases among men who have sex with men.

Zoetis Gets US FDA Emergency Use Nod for Treatment for Screwworm in Dogs

The U.S. Food and Drug Administration on Thursday issued an emergency use authorization for Zoetis' ⁠flea and tick drug to treat New World screwworm (NWS) infestations in...

Changes to NVAC Trigger Concerns

The HHS is seeking new members who can discuss immunization alternatives like ‘healthy lifestyle’ strategies and dietary supplements.

Congo Says Ebola Outbreak Spreads to Northeastern Bas-Uele Province

The Ebola outbreak in Democratic Republic of ⁠Congo has spread to a sixth province, Bas-Uele, located in ⁠the northeast of the country, the communications ministry ⁠said on...

Recommended News For You

Will a Mindfulness-Based Treatment for Depression Increase Recovery Rates?

Alkem introduces cetuximab under the trade name Cetuxa in India.

In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.

Scientists are investigating the prevention of recurrent breast cancer, which frequently results in death.

Why alarm is easing over a rise in pancreatic cancer among the young

The risk of lung cancer recurrence is linked to hypoxemia brought on by sleep apnea.

Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients

Recommended Articles For You

Strategic Concepts in Hematology for Modern Medicine 

Exploring the Use of Bevacizumab in Treating Different Types of Cancers  

Bridging Heart and Cancer Care: The Essential Framework of a Modern Cardio-Oncology Program 

Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

TCL1A Protein Identified as Predictor of Blinatumomab Response in Relapsed B-ALL

2.

Health researchers discuss Medicaid cancer screening trends, best practices

3.

Taking Charge of Your Cancer Journey.

4.

On all CAR-T products, the FDA is calling for a new boxed warning.

5.

Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma

1.

Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes

2.

Breaking Down Leukocytoclastic Vasculitis: Causes, Symptoms and Treatment

3.

Getting to Know RDW and SD: How They Relate to Anemia, Inflammation, and More 

4.

A Review on Genetic Predispositions and Clinical Advancements of Multiple Myeloma Cancer

5.

AI-Powered Rehabilitation: A Game Changer for Hemophilia Management

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

3.

Navigating the Complexities of Ph Negative ALL - Part II

4.

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

5.

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot